10-Q: DT Cloud Acquisition Corporation Reports Net Income of $452,085 for Q1 2025, Faces Going Concern Uncertainty

Sentiment:

Quarterly Report


DT Cloud Acquisition Corporation reports a net income for Q1 2025 but acknowledges substantial doubt about its ability to continue as a going concern due to the approaching deadline for completing a business combination.

Delay expectedThe company has extended the period to consummate a Business Combination up to eighteen times (i.e., until August 23, 2026) subject to the sponsor depositing additional funds for each one-month extension into the trust account.
Capital raiseThe company and Maius have agreed to use commercially reasonable efforts to obtain executed subscription agreements for an aggregate investment amount of no less than $10,000,000 from third party investors (such investors, collectively, with any permitted assignees or transferees, the PIPE Investors), pursuant to which the PIPE Investors make or commit to make private equity investments in us, Maius or Pubco to purchase shares of us, Maius or Pubco in connection with a private placement, and/or enter into backstop or other alternative financing arrangements with potential investors (a PIPE Investment).Up to $300,000 of Working Capital Loan may be convertible upon consummation of our business combination into private units at a price of $10.00 per unit.
Worse than expectedThe company's management has expressed substantial doubt about its ability to continue as a going concern if it fails to complete a business combination within the prescribed timeframe.

Summary

  • DT Cloud Acquisition Corporation is a blank check company formed to effect a business combination.
  • The company reported a net income of $452,085 for the three months ended March 31, 2025, compared to a net income of $43,875 for the same period in 2024.
  • As of March 31, 2025, the company had $1 in cash and $53,622,021 in a trust account.
  • The company has entered into a business combination agreement with Maius Pharmaceutical Co., Ltd.
  • The company faces a deadline to complete its business combination, and failure to do so raises substantial doubt about its ability to continue as a going concern.
  • The company has extended the period to consummate a Business Combination up to eighteen times (i.e., until August 23, 2026) subject to the sponsor depositing additional funds for each one-month extension into the trust account.

Sentiment

Score: 4

Explanation: The report presents mixed signals. While the company achieved net income, the going concern warning and material weaknesses in internal controls raise significant concerns. The reliance on sponsor funding and the uncertainty surrounding the business combination add to the negative sentiment.

Positives

  • The company generated a net income of $452,085 for the three months ended March 31, 2025, a significant increase compared to the $43,875 net income for the same period in 2024.
  • The company holds a substantial amount of cash and investments in its trust account, totaling $53,622,021 as of March 31, 2025.
  • The company has a definitive business combination agreement in place with Maius Pharmaceutical Co., Ltd.

Negatives

  • The company's management has expressed substantial doubt about its ability to continue as a going concern if it fails to complete a business combination within the prescribed timeframe.
  • The company had only $1 in cash outside of the trust account as of March 31, 2025.
  • The company's disclosure controls and procedures were not effective as of March 31, 2025, due to material weaknesses in internal control over financial reporting.

Risks

  • The company's ability to continue as a going concern is dependent on completing a business combination within a specific timeframe.
  • The company's lack of cash outside the trust account could limit its operational flexibility.
  • The company's material weaknesses in internal control over financial reporting could lead to errors or irregularities in its financial statements.
  • Geopolitical instability and economic uncertainties, such as the Russia-Ukraine conflict and the Israel-Hamas conflict, could negatively impact the global economy and capital markets, affecting the company's business combination prospects.
  • The company's proposed business combination with Maius is subject to regulatory approvals, including from the China Securities Regulatory Commission (CSRC), which may be delayed or not obtained.
  • The company may not be able to secure PIPE financing as contemplated in the Business Combination, which could make the Business Combination less attractive to some investors.

Future Outlook

The company intends to complete a business combination before the mandatory liquidation date, but there is no assurance that it will be able to do so.

Industry Context

SPACs have faced increased scrutiny and market volatility, making it more challenging to complete business combinations. The company's situation reflects these broader industry trends.

Comparison to Industry Standards

  • Comparable companies in the SPAC sector, such as Gores Metropoulos II, Inc. and Churchill Capital Corp VII, have also faced challenges in completing business combinations within the specified timeframes.
  • The level of cash held in the trust account is within the typical range for SPACs of similar size, but the low cash balance outside the trust is a concern.
  • The net income reported is positive, but the going concern warning overshadows this result, as the primary goal of a SPAC is to complete a business combination.

Related Party Transactions

  • As of March 31, 2025 and December 31, 2024, the Company had a temporary advance of $333,528 and $129,759 from the Sponsor, respectively.
  • An affiliate of the Sponsor will agree that, commencing from the date that the Company's securities are first listed on NASDAQ through the earlier of the Company's consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, administrative and support services, as the Company may require from time to time.
  • In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company's directors and officers may, but are not obligated to, loan the Company funds as may be required (Working Capital Loans).

Stakeholder Impact

  • Shareholders face the risk of liquidation if the business combination is not completed.
  • Employees of the target company face uncertainty regarding their future employment.
  • The company's creditors face the risk of non-payment if the company liquidates.

Next Steps

  • The company needs to secure the necessary regulatory approvals, including from the CSRC, for the business combination with Maius.
  • The company needs to obtain PIPE financing to support the business combination.
  • The company needs to address the material weaknesses in its internal control over financial reporting.
  • The company needs to continue to seek to complete a Business Combination before the mandatory liquidation date.

Key Dates

DateDescription
2022-07-07DT Cloud Acquisition Corporation incorporated as a Cayman Islands exempted company
2024-02-14Registration statement for the Company's Initial Public Offering was declared effective
2024-02-23Company consummated the Initial Public Offering of 6,900,000 units
2024-02-23Company consummated the sale of 234,500 units in a private placement to DT Cloud Capital Corp.
2024-09-03Company entered into a non-binding letter of intent with Shanghai Maius Pharmaceutical Technology Co., LTD
2024-10-22Company entered into a business combination agreement with Maius Pharmaceutical Co., Ltd.
2025-01-20Company entered into certain Subscription Agreement with Maius, Pubco and certain investor
2025-02-22Company deposited $207,000 into the Trust Account in order to extend the amount of available time to complete a business combination until March 23, 2025
2025-03-20Company held an extraordinary general meeting of shareholders and passed a special resolution to amend our amended and restated memorandum and articles of association then effective, giving the Company the right to extend the date by which it has to complete a business combination up to May 23, 2026
2025-03-24In connection with the stockholders vote at the Extraordinary General Meeting, 1,868,367 shares were redeemed by certain shareholders at a price of approximately $10.61 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $19,821,345
2025-03-25Company deposited $150,949 into the Trust Account in order to extend the amount of available time to complete a business combination until April 23, 2025
2025-04-23Company held an extraordinary general meeting of shareholders and obtain approval by special resolution, the Company's amended and restated memorandum and articles of association to extend the maximum period the Company may extend the period of time to consummate a Business Combination, on a month-to-month basis and subject to the sponsor depositing additional funds for each one-month extension into the trust account, from up to fifteen times (i.e., until May 23, 2026) to up to eighteen times (i.e., until August 23, 2026)
2025-04-23Trust Amendment Proposal was approved to amend by ordinary resolution, the Investment Management Trust Agreement, dated February 20, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, to reflect the Extension Amendment Proposal
2025-04-23In connection with the vote to approve the Extension Amendment Proposal and the Trust Amendment Proposal, holders of 326,904 ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.68 per share, for an aggregate redemption amount of approximately $3,492,160
2025-06-30Outside Date for Business Combination Agreement
2026-08-23Extended deadline for the Company to consummate a business combination

Keywords

business combination, SPAC, acquisition, financial statements, trust account, redemption, Maius, DT Cloud Acquisition Corporation, going concern, PIPE financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.